Search
While many university students spend their summer break enjoying a bit of downtime, Will Kermode spent his in a laboratory.
The Kids Research Institute Australia has welcomed the Federal Government's commitment to legislate the Medical Research Future Fund
Perth's The Kids Research Institute Australia has welcomed the passing of legislation to establish the Medical Research Future Fund (MRFF).
Tasmania's Child and Family Centres are having a positive impact on parent's use and experiences of services and supports for young children
Professor Carol Bower has received the prestigious ICBDSR Distinguished Service Award for her work on birth defects - a career that spans 35 years.
Nine researchers from The Kids Research Institute Australia have secured vital support through the WA Near Miss Awards, allowing them to continue innovative health projects that narrowly missed out on national funding.
Secondary students have the opportunity to hear from Associate Professor Asha Bowen, a 2018 L’Oreal-UNESCO Women in Science Fellow, in a free online event this National Science Week.
Online youth-focused health programs often include parent modules—that equip parents with skills to assist their child in improving their health—alongside youth-specific content. BRAVE Self-Help, an evidence-based program designed for children and teenagers with early signs of anxiety, is a popular Australian program that includes six parent modules.
Leclercia adecarboxylata is a rare cause of septic arthritis in children, and has intrinsic resistance to common antibiotics. We describe two cases of L. adecarboxylata septic arthritis in children that required re-presentation to hospital with prolonged treatment, and highlight the importance of considering L. adecarboxylata as a potential cause of infection among children with penetrating injuries and associated environmental exposure.
Antisense oligonucleotides are an emerging therapeutic option to treat diseases with known genetic origin. In the age of personalised medicines, antisense oligonucleotides can sometimes be designed to target and bypass or overcome a patient's genetic mutation, in particular those lesions that compromise normal pre-mRNA processing. Antisense oligonucleotides can alter gene expression through a variety of mechanisms as determined by the chemistry and antisense oligomer design.